phrykt

Revolution Medicines (RVMD) cash: $384M

Revolution Medicines held $384M in cash and cash equivalents on Dec 31, 2025, down 29.3% from $543M a year earlier.

From Revolution Medicines's filings with the SEC · Read the filing · RVMD stock page

Revolution Medicines cash by year

$108M2021$161M2022$696M2023$543M2024$384M2025

#1,034 of 4,171 US companies by cash · See the full ranking

Year endedCashChange
Dec 31, 2025$384M-29%
Dec 31, 2024$543M-22%
Dec 31, 2023$696M+331%
Dec 31, 2022$161M+49%
Dec 31, 2021$108M–

Cash of similar companies

Companies in the same industry as Revolution Medicines, by SEC industry code, with the closest cash. Each name opens the same page for that company.

CompanyCash, latest yearYear ended
Immunocore Holdings$468MDec 31, 2025
Vor Biopharma$396MDec 31, 2025
Revolution Medicines$384MDec 31, 2025
Kymera Therapeutics$357MDec 31, 2025
Crispr Therapeutics$348MDec 31, 2025
Scholar Rock Holding$324MDec 31, 2025
Taysha Gene Therapies$320MDec 31, 2025

Questions and answers

What is Revolution Medicines's cash?

Revolution Medicines held $384M in cash and cash equivalents on Dec 31, 2025, down 29.3% from $543M a year earlier.

Numbers as reported in Revolution Medicines's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology